Source:http://linkedlifedata.com/resource/pubmed/id/10659050
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-2-18
|
pubmed:abstractText |
Despite repeated exposures to HIV-1, some individuals remain seronegative. This study reports that sera from a fraction of exposed seronegative (ESN) subjects showed HIV-neutralizing activity; 5 of 17 ESN sera and none of 17 controls neutralized two different HIV-1 primary isolates (range of neutralizing titers: 1/20 to 1/60). The neutralizing activity was associated with the IgG fraction of 4 of 4 neutralizing ESN sera. Moreover, in 11 of 17 and 9 of 17 ESN sera (but none of the control sera) we found antibodies against HLA class I and CD4, respectively. One of the ESN sera (EU22) neutralized efficiently the primary virus derived from the seropositive partner and showed a good broadly cross-reactive neutralization. Immunoadsorption of two IgG fractions from EU19 and EU22 on peripheral blood mononuclear cells (PBMC) removed virus-neutralizing antibodies. The correlations between the ESN status and neutralizing activity (p<0.05), anti-HLA antibodies (p<0.0002), and anti-CD4 antibodies (p<0.001) were statistically significant. However, there was no statistically significant correlation between neutralizing activity and either anti-HLA or anti-CD4 antibodies. It can therefore be said that exposure to HIV-1 without seroconversion is, in some individuals, associated with HIV-neutralizing antibodies (not directed against viral antigens) and/or with anti-cell autoantibodies, which are possibly specific for cellular antigens involved in the infection/entry process.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD4,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/HLA Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR5
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0889-2229
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
109-15
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10659050-Antigens, CD4,
pubmed-meshheading:10659050-Autoantibodies,
pubmed-meshheading:10659050-Female,
pubmed-meshheading:10659050-Genotype,
pubmed-meshheading:10659050-HIV Antibodies,
pubmed-meshheading:10659050-HIV Infections,
pubmed-meshheading:10659050-HIV-1,
pubmed-meshheading:10659050-HLA Antigens,
pubmed-meshheading:10659050-Humans,
pubmed-meshheading:10659050-Immunoglobulin G,
pubmed-meshheading:10659050-Italy,
pubmed-meshheading:10659050-Male,
pubmed-meshheading:10659050-Polymerase Chain Reaction,
pubmed-meshheading:10659050-Precipitin Tests,
pubmed-meshheading:10659050-Receptors, CCR5,
pubmed-meshheading:10659050-Seroepidemiologic Studies
|
pubmed:year |
2000
|
pubmed:articleTitle |
Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.
|
pubmed:affiliation |
DIBIT and Infectious Diseases Clinic, San Raffaele Scientific Institute, Milan, Italy. lopalco.lucia@hsr.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|